14th October 2016
Byotrol plc
GRANT OF OPTIONS
DIRECTOR SHAREHOLDINGS
The Board of Byotrol plc ('Byotrol' or 'the Company'), the specialist anti-microbial technology company, announces that it has granted a total of 5,400,000 options over the Company's ordinary shares of 0.25 pence each ("Options" and "Ordinary Shares" respectively) representing 2.01 per cent of the issued share capital of the Company to two Directors and certain employees of the Company, upon the recommendation of the Company's Remuneration Committee. Details of the awards to the two Directors and the Company's Head of Finance, Denise Keenan (PDMR) are set out below:
|
No. of New Options Granted |
No. of Options held post Grant |
Shareholding in Company |
% Shareholding in Company after conversion of loan notes (fully diluted)* |
David Traynor |
2,000,000 |
7,700,000 |
4,850,514 |
1.81 |
Dr Trevor Francis |
2,000,000 |
4,850,000 |
1,110,359 |
0.81 |
Denise Keenan |
500,000 |
1,875,000 |
- |
- |
TOTAL |
4,500,000 |
|
|
|
The remaining Options are being awarded to a number of employees of the Company. The new Options are exercisable at 4.125 pence per Ordinary Share between 14 October 2017 and expire in tranches on varying dates up to 14 April 2024.
The new Options are being granted in the Company's Enterprise Management Incentive Scheme.
Enquiries:
Byotrol plc |
01925 742 000 |
David Traynor - Chief Executive
|
|
|
|
|
|
finnCap Ltd |
020 7220 0500 |
Geoff Nash / Carl Holmes / James Thompson- Corporate Finance |
|
Mia Gardner - Corporate Broking |
|
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.
Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens.
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
David Traynor |
2. |
Reason for the Notification |
|
a) |
Position/status |
CEO |
b) |
Initial notification/Amendment |
Initial |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Byotrol Plc |
b) |
LEI |
N/A |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the Financial instrument, type of instrument |
2,000,000 options over ordinary shares of 0.25p each in the capital of Byotrol Plc |
Identification code |
GB00B0999995 |
|
b) |
Nature of the transaction |
Award of Options |
c) |
Price(s) and volume(s) |
N/A |
d) |
Aggregated information: |
2,000,000 options over ordinary shares of 0.25p each in the capital of Byotrol Plc |
e) |
Date of the transaction |
14th October 2016 |
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |
5. |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Dr Trevor Francis |
6. |
Reason for the Notification |
|
a) |
Position/status |
Chief Technology Officer |
b) |
Initial notification/Amendment |
Initial |
7. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Byotrol Plc |
b) |
LEI |
N/A |
8. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the Financial instrument, type of instrument |
2,000,000 options over ordinary shares of 0.25p each in the capital of Byotrol Plc |
Identification code |
GB00B0999995 |
|
b) |
Nature of the transaction |
Award of Options |
c) |
Price(s) and volume(s) |
N/A |
d) |
Aggregated information: |
2,000,000 options over ordinary shares of 0.25p each in the capital of Byotrol Plc |
e) |
Date of the transaction |
14th October 2016 |
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |
9. |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Denise Keenan |
10. |
Reason for the Notification |
|
a) |
Position/status |
Head of Finance and Company Secretary (PDMR) |
b) |
Initial notification/Amendment |
Initial |
11. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Byotrol Plc |
b) |
LEI |
N/A |
12. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the Financial instrument, type of instrument |
500,000 options over ordinary shares of 0.25p each in the capital of Byotrol Plc |
Identification code |
GB00B0999995 |
|
b) |
Nature of the transaction |
Award of Options |
c) |
Price(s) and volume(s) |
N/A |
d) |
Aggregated information: |
500,000 options over ordinary shares of 0.25p each in the capital of Byotrol Plc |
e) |
Date of the transaction |
14th October 2016 |
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |